# Sonoma Pharmaceuticals, Inc.: Form 8-K, filed Jan 10, 2024

- Company: [Sonoma Pharmaceuticals, Inc.](/companies/snoa.md) (CIK 1367083)
- Form: 8-K
- Filed: 2024-01-10
- Accepted by EDGAR: Jan 10, 2024, 07:30 ET
- Period: 2024-01-10
- Accession: 0001683168-24-000168
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1367083/000168316824000168/sonoma_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1367083/000168316824000168/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1367083/000168316824000168/sonoma_8k.htm

Filed Jan 10, 2024.
Source: SEC EDGAR, the filing index for accession 0001683168-24-000168. Last ingested by Listed: Nov 11, 2026, 00:17 ET. No prices; not investment advice.
